Drug Profile
Hepapoietin - SnowBrand Pharmaceuticals
Alternative Names: HPO - SnowBrand PharmaceuticalsLatest Information Update: 20 Oct 2010
Price :
$50
*
At a glance
- Originator SnowBrand Pharmaceuticals
- Class Hepatoprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Liver disorders
Most Recent Events
- 31 Jul 2001 No-Development-Reported for Liver disorders in USA (Unknown route)
- 09 Nov 1998 New profile
- 09 Nov 1998 Preclinical development for Liver disorders in USA (Unknown route)